- Home
- ARGX vs ZBH Comparison
ARGX vs ZBH Comparison
Compare ARGX & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- ZBH
- Stock Information
- Founded
- ARGX 2008
- ZBH 1927
- Country
- ARGX Netherlands
- ZBH United States
- Employees
- ARGX N/A
- ZBH N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- ZBH Industrial Specialties
- Sector
- ARGX Health Care
- ZBH Health Care
- Exchange
- ARGX Nasdaq
- ZBH Nasdaq
- Market Cap
- ARGX 40.4B
- ZBH N/A
- IPO Year
- ARGX 2017
- ZBH N/A
- Fundamental
- Price
- ARGX $614.76
- ZBH $101.51
- Analyst Decision
- ARGX Strong Buy
- ZBH Buy
- Analyst Count
- ARGX 20
- ZBH 22
- Target Price
- ARGX $699.56
- ZBH $124.15
- AVG Volume (30 Days)
- ARGX 448.6K
- ZBH 2.3M
- Earning Date
- ARGX 05-08-2025
- ZBH 05-05-2025
- Dividend Yield
- ARGX N/A
- ZBH 0.95%
- EPS Growth
- ARGX N/A
- ZBH N/A
- EPS
- ARGX 12.78
- ZBH 4.43
- Revenue
- ARGX $2,248,205,000.00
- ZBH $7,678,600,000.00
- Revenue This Year
- ARGX $60.97
- ZBH $3.82
- Revenue Next Year
- ARGX $31.50
- ZBH $4.74
- P/E Ratio
- ARGX $44.63
- ZBH $22.91
- Revenue Growth
- ARGX 77.22
- ZBH 3.85
- 52 Week Low
- ARGX $352.77
- ZBH $93.10
- 52 Week High
- ARGX $678.21
- ZBH $123.96
- Technical
- Relative Strength Index (RSI)
- ARGX 57.38
- ZBH 44.54
- Support Level
- ARGX $593.31
- ZBH $93.10
- Resistance Level
- ARGX $604.77
- ZBH $103.34
- Average True Range (ATR)
- ARGX 21.09
- ZBH 3.65
- MACD
- ARGX 5.10
- ZBH -0.15
- Stochastic Oscillator
- ARGX 98.32
- ZBH 54.57
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.